Nickel chelation therapy as an approach to combat multi-drug resistant enteric pathogens
Abstract The nickel (Ni)-specific chelator dimethylglyoxime (DMG) has been used for many years to detect, quantitate or decrease Ni levels in various environments. Addition of DMG at millimolar levels has a bacteriostatic effect on some enteric pathogens, including multidrug resistant (MDR) strains...
Guardado en:
Autores principales: | Stéphane L. Benoit, Alan A. Schmalstig, John Glushka, Susan E. Maier, Arthur S. Edison, Robert J. Maier |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ba948ee605c447938767fdd68a6d105c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The nickel-chelator dimethylglyoxime inhibits human amyloid beta peptide in vitro aggregation
por: Stéphane L. Benoit, et al.
Publicado: (2021) -
Mua (HP0868) Is a Nickel-Binding Protein That Modulates Urease Activity in <named-content content-type="genus-species">Helicobacter pylori</named-content>
por: Stéphane L. Benoit, et al.
Publicado: (2011) -
Mua (HP0868) Is a Nickel-Binding Protein That Modulates Urease Activity in <named-content content-type="genus-species">Helicobacter pylori</named-content>
por: Stéphane L. Benoit, et al.
Publicado: (2011) -
Chiral DOTA chelators as an improved platform for biomedical imaging and therapy applications
por: Lixiong Dai, et al.
Publicado: (2018) -
Combating Intracellular Pathogens with Nanohybrid-Facilitated Antibiotic Delivery
por: Bose RJC, et al.
Publicado: (2020)